FDA Approved: DEFERIPRONE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Deferiprone submitted by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta Thalassemia Major
• Iron Overload

Drugs mentioned

• Deferiprone (deferiprone)

Snippet

SUPPL AP for DEFERIPRONE (DEFERIPRONE)